|
Match
|
Document |
Document Title |
|
|
5756469 |
Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
The present invention is based, in part, upon the discovery that the use of pyruvate in combination with a cortisol blocker, such as phosphatidylserine, produces a synergistic effect in increasing...
|
|
|
5750150 |
Compositions for treating affected tissues, method for the preparation and usage thereof
Injectable compositions for treating affected tissues are prepared by formulating sodium hydrogen sulfite with all other components except tannic acid to yield a first mixture and adding tannic...
|
|
|
5750563 |
Preparation for epidermis
A preparation for epidermis containing kojic acid and/or its derivative, which has improved preparation stability, is provided. The preparation stability is imparted by adding to the preparation at...
|
|
|
5747048 |
Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
A method of producing monoclonal antibodies that bind to human cancer-associated mucin-type glycoprotein antigens comprising: (1) immunizing a host with a core structure of a mucin-type...
|
|
|
5747462 |
Pharmaceutically active compounds and their use
The present invention relates to the area of pharmacology; its objective is to solve the technical problem of inflammation, pain, pruritus and local hyperthermia in human beings and animal species....
|
|
|
5747461 |
Synergistic administration of cyclosporine and fructose diphosphate
This invention discloses a method of using fructose-1,6-diphosphate (FDP) to help suppress the rejection of internal organs such as kidneys, hearts, etc. At least three major advantages of FDP in...
|
|
|
5747055 |
Insecticidal and pesticidal complex, and method for destroying insects and ectoparasites
An insecticidal and pesticidal complex including an active ingredient combined with an element to insert and diffuse the active ingredient within a vacuum cleaner dust bag. The element is shaped or...
|
|
|
5739115 |
Sulfated maltooligosaccharides with heparin-like properties
A novel class of highly sulfated maltooligosaccharide having heparin-like activity is described, as well as methods for using these oligosaccharides to treat certain diseases including cancer, and...
|
|
|
5736508 |
Methods for treatment of scar tissue
Methods are presented for treatment in eliminating or reducing the appearance of scar tissue by administration of streptolysin O.
|
|
|
5733579 |
Oral rehydration solution containing indigestible oligosaccharides
An oral rehydration solution contains indigestible oligosaccharides. Diarrhea related dehydration requires fluid and electrolyte replacement. The primary etiology of antibiotic-associated diarrhea...
|
|
|
5733884 |
Enteral formulation designed for optimized wound healing
The present invention provides an enteral nutritional formulation that meets the nutrient requirements of patients with wounds. The present invention meets the unique nutrient needs of the acute or...
|
|
|
5733924 |
DC 107 derivatives and treatment methods
DC107 derivatives represented by the formula (I): ##STR1## or pharmacologically acceptable slats thereof, wherein R 1 is hydrogen, lower alkoxyalkyl, aralkyloxyalkyl, lower alkoxyalkoxyalkyl,...
|
|
|
5731291 |
Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans
A method is disclosed for preparing a partially lyophilized (freeze-dried) powder or solidified cake containing fructose-1,6-diphosphate (FDP), a naturally-occurring intermediate in glycolysis....
|
|
|
5731292 |
Dihydrochalcone derivatives which are hypoglycemic agents
A method for prophylaxis or treatment of diabetes, which comprises administering to a patient with diabetes an effective amount of a dihydrochalcone derivative of the formula I!: ##STR1## wherein...
|
|
|
5728681 |
Infusion preparation and two compartment container containing the preparation
A container filled with infusion liquids useful for preparation of an infusion liquid containing sugars, amino acids, electrolytes, a fat emulsion and vitamins. A container having two compartments...
|
|
|
5728675 |
Antemortem nutrient supplement for livestock
The invention relates to an antemortem stress supplement for livestock containing one or more sources of electrolytes including sodium, potassium and magnesium, one or more sources of amino acids...
|
|
|
5726146 |
Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
Dietary supplement formulation which increases lean body mass without concomitant increase of body fat mass, an effect parallel to that seen with usage of synthetic anabolic steroidal compounds but...
|
|
|
5723149 |
Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
The invention relates to the use of Medicago saponins for the preparation of cosmetic or pharmaceutical compositions. The invention provides for the incorporation of 0.01% to 5% by weight of a...
|
|
|
5723504 |
Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
Novel Amadori reaction compounds have the formula R 1 --NH--R 2 , wherein R 1 comprises the D-form of a 1-amino-1-deoxy-2-ketose radical derived from a sugar radical selected from the group of...
|
|
|
5723498 |
Composition capable of releasing acrolein and its use
A composition which is capable of releasing acrolein and is easy to handle contains (i) an acetal of acrolein with a C 1 -6 alcohol with 1 to 4 hydroxyl groups and (ii) an acid soluble therein and...
|
|
|
5723446 |
Enteral formulation designed for optimized nutrient absorption and wound healing
The present invention provides an enteral nutritional formulation that meets the nutrient requirements of intensive care patients who may have compromised absorption capacity. The present invention...
|
|
|
5714472 |
Enternal formulation designed for optimized nutrient absorption and wound healing
The present invention provides an enteral nutritional formulation that meets the nutrient requirements of intensive care patients who may have compromised absorption capacity. The present invention...
|
|
|
5712123 |
Mixture having antitumor activities
A purified hot-water extract from Mycobacterium bovis (BCG vaccine) has been found to have significant antitumor activity against a mouse bladder tumor model and a murine sarcoma in vivo, but not...
|
|
|
5707970 |
Arginine silicate complex and use thereof
An arginine silicate-containing complex and its use in the prevention and treatment of atherosclerosis and as a dietary supplement. The arginine silicate complex is synthesized by combining...
|
|
|
5698524 |
Method of treating a patient suffering from a viral infection
A method of treating a patient suffering with a viral infection (such as HIV) by administering to the patient an effective anti-viral amount of a composite molecular active substance group, which...
|
|
|
5698525 |
Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
Methods of reducing post-prandial fluctuations in plasma levels of large, neutral amino acids (LNAA), as well as compositions useful in that method. The compositions comprise a carbohydrate to...
|
|
|
5690963 |
Freeze dried red blood cells
A process and medium are disclosed for the lyophilization of cells, specifically red blood cells and platelets, and cell-like matter, which comprises the use of solution including a carbohydrate,...
|
|
|
5690967 |
Compositions for improved topical delivery of lactic acid
Compositions for improved topical delivery of lactic acid comprising lactic acid and an amphoteric or pseudoamphoteric agent.
|
|
|
5686491 |
Infant formula
The present invention provides an infant formula for infants with metabolic disorders in fatty acid catabolism such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD), long-chain acyl-CoA...
|
|
|
5686132 |
Glucans having a cycle structure, and processes for preparing the same
The present invention provides glucans and derivatives thereof which are useful as raw materials in the starch processing industries, food and drink compositions, food additive compositions, and...
|
|
|
5681855 |
PGE.sub.1 emulsion composition kit
The invention concerns a kit for the preparation of an emulsion containing prostaglandin E 1 , a method of preparing the emulsion and a method of preparing the emulsion composition contained in the...
|
|
|
5681564 |
Flavored, ready to use activated charcoal antidote
To provide a therapeutic dose of an aqueous slurry of activated charcoal to a poisoning victim, an opaque straw is coated internally with a viscous flavoring solution and the slurry is sucked up...
|
|
|
5679347 |
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
The present invention is based on the observation that CD1 functions to present foreign and autoimmune antigens to a select subpopulation of T-cells. Based on this observation, the present...
|
|
|
5670157 |
Method for reducing and controlling immunoglobulin concentrations
The present invention provides a method for reducing and controlling antigen-specific immunoglobulin concentrations in a patient. In addition, the present invention provides a method for...
|
|
|
5668117 |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
Therapeutic compositions comprising an effective amount of at least one carbonyl trapping agent alone or in combination with a therapeutically effective of a co-agent or medicament are disclosed....
|
|
|
5661123 |
Enteral composition for malabsorbing patients
The present invention provides a method for providing nutrition to non-catabolic and moderately catabolic patients. Pursuant to the present invention, the enteral composition includes a peptide...
|
|
|
5661124 |
Blood substitutes
The present invention provides blood substitutes comprised of recombinantly produced mutant hemoglobin having an osmolarity greater than 303 milliosmoles per liter and less than 800 milliosmoles...
|
|
|
5658894 |
Compositions for inhibiting restenosis
Polyionic derivatives of cyclodextrins and methods for preparing these derivatives are provided in which a polyionic derivative of cyclodextrin is combined with a growth factor, preferably a...
|
|
|
5656588 |
Wound healing formula
The present invention provides a composition that stimulates and improves wound healing in a patient in need of same. To this end, a method for stimulating wound healing comprising the step of...
|
|
|
5654282 |
Selectin binding glycopeptides
Glyco-amino acids and glycopeptides having three-dimensionally stable configurations are described. These glyco-amino acids and glycopeptides have glycoside functional groups, such as fucose and...
|
|
|
5653967 |
Cosmetic product including water soluble fiber
A cosmetic component is produced by dispersing in water a water-soluble fiber composed of about 4 to 6 weight percent beta glucan, about 1 to 5 weight percent fat, about 80 to 94 weight percent...
|
|
|
5654280 |
Pharmaceutical composition
A pharmaceutical composition comprising a pharmaceutically active ingredient selected from the group consisting of trisphosphorylated pentoses, pentitols or anhydropentitols, trisphosphorylated...
|
|
|
5653984 |
Extract of periwinkle seed and compositions containing the same
Extracts of periwinkle seed, obtained by bioconversion, and compositions containing such extracts display the property of stimulating mitochondrial cell respiration and of stimulating the cell...
|
|
|
5643883 |
Glucose-6-phosphate uptake inhibitors and novel uses thereof
The present invention provides a composition of matter comprising an inhibitor of glucose-6-phosphate uptake. Also provided is a method of inhibiting the import of glucose-6-phosphate into the...
|
|
|
5641760 |
Method of treating candida infection
A method of treating Candida albicans infection is disclosed. In one embodiment, for treatment of oral or vaginal infection, the treatment is by topical application of a composition of conjugates...
|
|
|
5639738 |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
A method of treating a mammal for a condition of the skin or exposed tissue selected from the group consisting of basal cell carcinoma and actinic keratosis is provided. The method consists...
|
|
|
5639732 |
Phosphorous-containing cysteine and serine protease inhibitors
The present invention is directed to novel phosphorous-containing inhibitors of cysteine or serine proteases. Methods for the use of the protease inhibitors are also described.
|
|
|
5639731 |
Amino acids for the preparation of a beverage
The present invention is directed to a method of improving the mental performance during strenuous physical activity and for delaying mental exhaustion due to physical activity as well as to...
|
|
|
5637563 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Mistletoe extract and method
A method for making and identifying mistletoe extracts as being of a pharmaceutical grade which is useful in treating AIDS, cancers and other diseases where the immune system is suppressed. The...
|
|
|
5637301 |
Obtention of ice nucleating agent from sea buckthorn
Sea buckthorn berry juice and aqueous extracts obtained from sea buckthorn berry and leaf tissue provide an ice nucleating agent and thereby operate, upon addition of the juice and/or extract to a...
|